Coronavirus: Indian company Bharat Biotech working on developing 'Coroflu' vaccine for COVID-19 patients

Coronavirus: Indian company Bharat Biotech working on developing ‘CoroFlu’ vaccine for COVID-19 patients

News

Coronavirus Vaccine: Till now, more than 82 thousand people worldwide have died from the deadly coronavirus. At the same time, more than 14 lakh people are infected with this virus. No effective medicine has been discovered so far to eliminate this virus, but big scientists from all over the world have now started searching for medicines. The great thing is that now everyone’s eyes are fixed on India for the coronavirus vaccine. Why is it like this? Read this report

Advertisement

Coroflu vaccine may prove to be an anti dose of virus

Actually, a vaccine named Coroflu is in great news these days. The Coroflu Vaccine can prove to be an anti dose of coronavirus that has killed thousands of people. It is claimed by Dr. Krishna Ella, chairman of Bharat Biotech, a vaccine company.

Bharat Biotech Chairman Dr. Krishna Ella has said that we have created a vaccine named CoroFlu, hope that the vaccine will end the epidemic like Coronavirus. Let me tell you that Hyderabad company Bharat Biotech is working closely with the founders of American company Flugen Yoshi Kawaoka and Gabriel Newman on this potential vaccine of coronavirus.

Know about Coroflu

Coroflu is being developed on the basis of the flu vaccine M2SR of the Fluagen Company of America. The Coroflu vaccine will be delivered to the patient’s body via the nose. Human testing of the vaccine is possible by the end of the year. At the same time, it can be tested on humans in the world’s most powerful country by October.

Bharat Biotech has made several successful vaccines

India biotech company has made a successful vaccine for dangerous epidemics like Chikungunya and Zika virus. If the coronavirus vaccine is also successful, then it will be a big achievement for this company, but it may take a long time.

Facebook Comments